{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:52:09Z","timestamp":1781585529205,"version":"3.54.5"},"reference-count":54,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"unspecified","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjonc"],"accepted":{"date-parts":[[2026,5,28]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Cervical cancer is a largely preventable disease, yet over 90% of its global mortality occurs in low and middle income countries(LMICs), reflecting profound inequities in access to screening and treatment. Traditional multivisit cervical cancer prevention models have been inadequate in these settings, largely due to high rates of loss to follow-up and insufficient health system infrastructure. In response, the WHO recommends the screen-and-treat (SAT) approach, which offers treatment based on a positive screening result, without requiring histological confirmation, preferably within a single visit. This narrative review synthesises evidence on the clinical effectiveness and operational feasibility of SAT in resource-constrained settings, with a focus on screening modalities, visual inspection with acetic acid (VIA) and human papillomavirus (HPV) testing and treatment options including cryotherapy, thermal ablation (TA) and large-loop excision of the transformation zone (LLETZ). While VIA is low-cost and provides immediate results, its accuracy is limited by provider-dependent subjectivity. HPV testing, particularly through point-of-care platforms and self-sampling, offers higher sensitivity and improved acceptability and is now the WHO-recommended primary screening modality. For treatment, portable TA devices have emerged as a logistically superior alternative to cryotherapy in LMICs, eliminating the need for compressed gas while maintaining comparable efficacy. Recent evidence further confirms that TA is non-inferior to LLETZ in real-world SAT settings, challenging the long-held perception that ablative therapies are clinically inferior. Concerns about overtreatment persist but must be weighed against the considerably greater risk of undertreatment in fragmented health systems. Women living with HIV require particular attention, given higher HPV prevalence, lower test specificity, more rapid disease progression and substantially lower post-treatment cure rates, necessitating tailored management protocols. The SAT approach represents a pragmatic, evidence-based strategy for achieving cervical cancer elimination in LMICs, but its effectiveness will depend on contextually appropriate implementation, integration within existing primary healthcare services and dedicated strategies for high-risk populations.<\/jats:p>","DOI":"10.1136\/bmjonc-2025-000827","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:00:10Z","timestamp":1781582410000},"page":"e000827","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7492-323X","authenticated-orcid":false,"given":"Laura","family":"Cardoso","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"},{"name":"School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4959-8157","authenticated-orcid":false,"given":"Rakiya","family":"Saidu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-8665","authenticated-orcid":false,"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, New York, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2026061521000708000_5.1.e000827.1","unstructured":"Ferlay J , Ervik M , Lam F , et al . Global cancer observatory: cancer today (version 1.1). Lyon, France; 2024. Available: https:\/\/gco.iarc.who.int\/today"},{"key":"2026061521000708000_5.1.e000827.2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ypmed.2016.12.030","article-title":"The time is now to implement HPV testing for primary screening in low resource settings","volume":"98","author":"Kuhn","year":"2017","journal-title":"Prev Med"},{"key":"2026061521000708000_5.1.e000827.3","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026061521000708000_5.1.e000827.4","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026061521000708000_5.1.e000827.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43467-2","article-title":"Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa","volume":"13","author":"Denny","year":"2023","journal-title":"Sci Rep"},{"key":"2026061521000708000_5.1.e000827.6","unstructured":"World Health Organisation . Comprehensive cervical cancer control: a guide to essential practice. 2nd edn. World Health Organization, 2014."},{"key":"2026061521000708000_5.1.e000827.7","unstructured":"World Health Organisation . WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/342365\/9789240030824-eng.pdf?sequence=1"},{"key":"2026061521000708000_5.1.e000827.8","unstructured":"Bank W . The World by Income and Region, 2024. Available: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html"},{"key":"2026061521000708000_5.1.e000827.9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21696"},{"key":"2026061521000708000_5.1.e000827.10","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828177d7"},{"key":"2026061521000708000_5.1.e000827.11","unstructured":"World Health Organisation . WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. World Health Organization; 2019."},{"key":"2026061521000708000_5.1.e000827.12","unstructured":"World Health Organisation . Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organisation; 2020."},{"key":"2026061521000708000_5.1.e000827.13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4344-8"},{"key":"2026061521000708000_5.1.e000827.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004143","article-title":"Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020)","volume":"20","author":"Yang","year":"2023","journal-title":"PLoS Med"},{"key":"2026061521000708000_5.1.e000827.15","doi-asserted-by":"crossref","DOI":"10.1186\/s43058-024-00566-z","article-title":"Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: a case study from the Proyecto Precancer","volume":"5","author":"Gilman","year":"2024","journal-title":"Implement Sci Commun"},{"key":"2026061521000708000_5.1.e000827.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.17.2173"},{"key":"2026061521000708000_5.1.e000827.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.08.003"},{"key":"2026061521000708000_5.1.e000827.18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ijc.30101","article-title":"Use of thermo-coagulation as an alternative treatment modality in a \u201cscreen-and-treat\u201d programme of cervical screening in rural Malawi","volume":"139","author":"Campbell","year":"2016","journal-title":"Int J Cancer"},{"key":"2026061521000708000_5.1.e000827.19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4161\/cbt.11.3.14686","article-title":"Molecular pathogenesis of cervical cancer","volume":"11","author":"Ibeanu","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"2026061521000708000_5.1.e000827.20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","article-title":"Cervical Cancer Screening: Past, Present, and Future","volume":"8","author":"Bedell","year":"2020","journal-title":"Sex Med Rev"},{"key":"2026061521000708000_5.1.e000827.21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.aogh.2014.09.014","article-title":"Screening for cancer in low- and middle-income countries","volume":"80","author":"Sankaranarayanan","year":"2014","journal-title":"Ann Glob Health"},{"key":"2026061521000708000_5.1.e000827.22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2016.11.029","article-title":"Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm","volume":"98","author":"Tota","year":"2017","journal-title":"Prev Med"},{"key":"2026061521000708000_5.1.e000827.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808516"},{"key":"2026061521000708000_5.1.e000827.24","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1002\/cam4.3329","article-title":"Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women","volume":"9","author":"Johnson","year":"2020","journal-title":"Cancer Med"},{"key":"2026061521000708000_5.1.e000827.25","doi-asserted-by":"crossref","unstructured":"Cubie HA , Campbell C . Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi. Womens Health (Lond) 2020;16. doi:10.1177\/1745506520914804","DOI":"10.1177\/1745506520914804"},{"key":"2026061521000708000_5.1.e000827.26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/ijc.34384","article-title":"Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study","volume":"152","author":"Baena","year":"2023","journal-title":"Int J Cancer"},{"key":"2026061521000708000_5.1.e000827.27","unstructured":"Mittal S , Basu P , Lucas E . Atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment. Lyon, France: IARC, 2020. Available: https:\/\/screening.iarc.fr\/atlasvia.php"},{"key":"2026061521000708000_5.1.e000827.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"2026061521000708000_5.1.e000827.29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7196\/SAMJ.2018.v109i1.13278","article-title":"South African women\u2019s perspectives on self-sampling for cervical cancer screening: A mixed-methods study","volume":"109","author":"Saidu","year":"2019","journal-title":"S Afr Med J"},{"key":"2026061521000708000_5.1.e000827.30","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2021.1199","article-title":"Changing the paradigm of cervical cancer prevention through introduction of HPV-testing: evaluation of the implementation process of the Jujuy Demonstration Project in Argentina","volume":"15","author":"Arrossi","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"2026061521000708000_5.1.e000827.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-025-03638-x","article-title":"A mixed-methods preliminary evaluation of an innovative treatment for cervical precancer in El Salvador\u2019s screen-and-treat program","volume":"25","author":"Soler","year":"2025","journal-title":"BMC Womens Health"},{"key":"2026061521000708000_5.1.e000827.32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.currproblcancer.2018.01.010","article-title":"Management of cervical premalignant lesions","volume":"42","author":"Basu","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"2026061521000708000_5.1.e000827.33","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00175"},{"key":"2026061521000708000_5.1.e000827.34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-0528.1991.tb10304.x","article-title":"Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experience","volume":"98","author":"Gordon","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"2026061521000708000_5.1.e000827.35","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.03089","article-title":"Overview of thermal ablation devices for treating precancerous cervical lesions in low-resource settings","volume":"12","author":"Boles","year":"2022","journal-title":"J Glob Health"},{"key":"2026061521000708000_5.1.e000827.36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jog.14139","article-title":"Thermo-coagulation versus cryotherapy for treatment of cervical precancers: A prospective analytical study in a low-resource African setting","volume":"46","author":"Chigbu","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"2026061521000708000_5.1.e000827.37","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/j.lanogw.2025.09.001","article-title":"Comparison of CO2-based cryotherapy, non-gas-based cryotherapy, and thermal ablation for cervical intraepithelial neoplasia grade 2 and 3: a randomised, controlled, phase 3 non-inferiority trial","volume":"1","author":"Cremer","year":"2025","journal-title":"The Lancet Obstetrics, Gynaecology, & Women's Health"},{"key":"2026061521000708000_5.1.e000827.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03080-w"},{"key":"2026061521000708000_5.1.e000827.39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1471-0528.17251","article-title":"Efficacy, acceptability and safety of ablative versus excisional procedure in the treatment of histologically confirmed CIN2\/3: A systematic review","volume":"130","author":"Zhang","year":"2023","journal-title":"BJOG"},{"key":"2026061521000708000_5.1.e000827.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.10.006"},{"key":"2026061521000708000_5.1.e000827.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68181-6"},{"key":"2026061521000708000_5.1.e000827.42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33290"},{"key":"2026061521000708000_5.1.e000827.43","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2021-001541","article-title":"Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis","volume":"10","author":"Piret","year":"2022","journal-title":"Fam Med Community Health"},{"key":"2026061521000708000_5.1.e000827.44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s43477-025-00164-8","article-title":"Healthcare Providers\u2019 Perspectives Regarding Barriers and Facilitators to Former Pap\/VIA-Based Screen-and-Treat Program in Iquitos, Peru","volume":"5","author":"Nussbaum","year":"2025","journal-title":"Glob Implement Res Appl"},{"key":"2026061521000708000_5.1.e000827.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074607","article-title":"Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a \u2018Screen-And-Treat\u2019 Program Integrated with HIV\/AIDS Care in Zambia","volume":"8","author":"Mwanahamuntu","year":"2013","journal-title":"PLoS ONE"},{"key":"2026061521000708000_5.1.e000827.46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ijgo.13808","article-title":"The use of thermal ablation in diverse cervical cancer \u201cscreen-and-treat\u201d service platforms in Zambia","volume":"157","author":"Mwanahamuntu","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"2026061521000708000_5.1.e000827.47","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833e163e"},{"key":"2026061521000708000_5.1.e000827.48","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026061521000708000_5.1.e000827.49","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"key":"2026061521000708000_5.1.e000827.50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56926-3","article-title":"A randomised controlled non-inferiority trial to compare the efficacy of \u201cHPV screen, triage and treat\u201d with \u201cHPV screen and treat\u201d approach for cervical cancer prevention among women living with HIV","volume":"16","author":"Joshi","year":"2025","journal-title":"Nat Commun"},{"key":"2026061521000708000_5.1.e000827.51","doi-asserted-by":"publisher","DOI":"10.1002\/IJC.34737"},{"key":"2026061521000708000_5.1.e000827.52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/15248399251370668","article-title":"Health System Strategies to Improve the Uptake of Cervical Cancer Screening in Sub-Saharan Africa: A Scoping Systematic Review","volume":"27","author":"Rivero-Mendoza","year":"2026","journal-title":"Health Promot Pract"},{"key":"2026061521000708000_5.1.e000827.53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0005166","article-title":"Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in Kenya","volume":"5","author":"Adhiambo","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2026061521000708000_5.1.e000827.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-17842-1","article-title":"Barriers to cervical cancer screening in Africa: a systematic review","volume":"24","author":"Mantula","year":"2024","journal-title":"BMC Public Health"}],"container-title":["BMJ Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjonc-2025-000827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:00:30Z","timestamp":1781582430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjoncology.bmj.com\/lookup\/doi\/10.1136\/bmjonc-2025-000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,15]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjonc-2025-000827"],"URL":"https:\/\/doi.org\/10.1136\/bmjonc-2025-000827","relation":{},"ISSN":["2752-7948"],"issn-type":[{"value":"2752-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}